多重診斷試劑市場規模、佔有率和成長分析:按試劑類型、診斷技術、應用、終端用戶產業和地區分類-2026-2033年產業預測
市場調查報告書
商品編碼
2160388

多重診斷試劑市場規模、佔有率和成長分析:按試劑類型、診斷技術、應用、終端用戶產業和地區分類-2026-2033年產業預測

Multiplex Testing Reagents Market Size, Share, and Growth Analysis, By Reagent Type (Antibodies, Antigens), By Testing Technology (Multiplex PCR, Multiplex Immunoassays), By Application, By End-Use Industry, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球多重診斷試劑市場價值為 14 億美元,預計到 2033 年將從 2025 年的 15.8 億美元成長至 42.1 億美元,預測期(2026-2033 年)的複合年成長率為 13.0%。

受感染疾病爆發和慢性病發病率上升(需要廣泛檢測)導致快速診斷需求不斷成長的推動,全球多重診斷試劑市場正經歷顯著成長。多重診斷試劑能夠同時檢測多種病原體和生物標記物,從而提高臨床、研究和公共衛生領域的效率。這個市場發展趨勢正從傳統的單一標靶檢測轉向先進的PCR平台,簡化工作流程、縮短檢測結果取得時間並降低檢查室成本。此外,即時診斷的興起凸顯了試劑研發創新的重要性,使製造商能夠提供攜帶式整合解決方案。人工智慧驅動的自動化技術透過最佳化標靶選擇和簡化檢測流程,進一步改變了市場格局,加速了其在各種醫療保健領域的應用。

全球多重診斷試劑市場成長要素

隨著感染疾病早期檢測的重要性日益凸顯,能夠從單一檢體中識別多種病原體的多重檢測試劑盒的需求也日益成長。實驗室正優先考慮效率、最佳化資源利用並縮短檢測結果報告時間,這推動了綜合試劑組的普及應用。這種對營運效率的關注不僅符合旨在改善患者預後的臨床目標,也有助於醫院、參考實驗室和即時檢測機構擴展檢測能力。因此,這一趨勢顯著促進了新興和成熟醫療網路中該市場的持續成長。

全球多重診斷試劑市場限制因素

多重檢測試劑的高成本源自於其複雜的生產流程和嚴格的品質保證措施,以確保結果的一致性和可靠性。資源匱乏的醫療機構往往面臨預算限制,難以投資這些專業產品。因此,許多醫療機構可能會推遲採用多重檢測,或選擇價格更低的單重檢測,從而阻礙市場成長。這種價格敏感度會影響先進多重檢測技術在各個診斷領域的廣泛應用,並影響創新解決方案的長期投資決策。

全球多重診斷試劑市場趨勢

全球多重試劑市場正呈現顯著的自動化趨勢,檢查室擴大採用先進的機器人液體處理平台。這些高通量系統透過最大限度地減少重複性任務、提高流程一致性並縮短設定時間,最佳化了多重試劑工作流程,使專業人員能夠專注於更重要的分析工作。此外,先進調度軟體的引入確保了試劑加載和儀器操作的無縫同步,從而保證了連續運作並維持高品質。這種向自動化的轉變不僅提高了檢體處理能力,促進了大規模臨床研究和快速診斷,而且還降低了錯誤率,增強了在各種監管環境下進行多參數檢測的信心。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響
    • 競爭公司之間的競爭
    • 替代品的威脅
    • 買方的議價能力
    • 新進入者的威脅
    • 供應商的議價能力

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球多重診斷試劑市場規模:按試劑類型分類

  • 抗體
  • 抗原
  • 核酸探針
  • 酵素
  • 檢測試劑
  • 其他

全球多重檢測試劑市場規模:依檢測技術分類

  • 多重PCR
  • 多重免疫檢測
  • 微陣列
  • 質譜分析
  • 其他

全球多重診斷試藥市場規模:依應用分類

  • 傳染病檢查
  • 癌症診斷
  • 基因檢測
  • 食品安全檢查
  • 環境測試
  • 其他

全球多重診斷試劑市場規模:依最終用途產業分類

  • 臨床診斷
  • 製藥和生物技術
  • 食品/飲料
  • 環境測試
  • 研究與學術
  • 其他

全球多重診斷試藥市場規模:按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要公司2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析,2025 年
  • 主要公司的完整公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較(2023-2025 年)

主要公司簡介

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Luminex
  • QIAGEN
  • Seegene
  • Merck KGaA
  • Illumina
  • Bio-Techne
  • Abcam
  • Revvity
  • Agilent Technologies
  • Roche Diagnostics
  • Abbott Laboratories
  • DiaSorin
  • Hologic
  • Danaher
  • Molecular Devices
  • GenMark Diagnostics
  • Quanterix
  • Tecan

結論與建議

簡介目錄
Product Code: SQMIG35J2842

Global Multiplex Testing Reagents Market size was valued at USD 1.4 Billion in 2024 and is poised to grow from USD 1.58 Billion in 2025 to USD 4.21 Billion by 2033, growing at a CAGR of 13.0% during the forecast period (2026-2033).

The global market for multiplex testing reagents is experiencing significant growth, driven by an increasing need for rapid diagnostics due to infectious disease outbreaks and the rising incidence of chronic conditions requiring extensive testing. Multiplex reagents facilitate the simultaneous detection of various pathogens or biomarkers, enhancing efficiency in clinical, research, and public health environments. This market evolution has transitioned from traditional single-target assays to advanced PCR platforms, allowing for streamlined workflows that reduce turnaround times and lower laboratory costs. Additionally, the rise of point-of-care diagnostics emphasizes innovation in reagent development, enabling manufacturers to deliver portable, integrated solutions. AI-driven automation is further transforming this landscape by optimizing target selection and simplifying assay processes, which promotes faster adoption across diverse healthcare settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Multiplex Testing Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Multiplex Testing Reagents Market Segments Analysis

Global multiplex testing reagents market is segmented by reagent type, testing technology, application, end-use industry and region. Based on reagent type, the market is segmented into Antibodies, Antigens, Nucleic Acid Probes, Enzymes, Detection Reagents and Others. Based on testing technology, the market is segmented into Multiplex PCR, Multiplex Immunoassays, Microarray, Mass Spectrometry and Others. Based on application, the market is segmented into Infectious Disease Testing, Cancer Diagnostics, Genetic Testing, Food Safety Testing, Environmental Testing and Others. Based on end-use industry, the market is segmented into Clinical Diagnostics, Pharmaceuticals & Biotechnology, Food & Beverage, Environmental Testing, Research & Academia and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Multiplex Testing Reagents Market

The increasing emphasis on early detection of infectious diseases has heightened the demand for multiplex testing reagents capable of identifying several pathogens from a single sample. Laboratories prioritize the efficiency of reducing turnaround times while optimizing resource utilization, which propels the acquisition of comprehensive reagent kits. This drive for operational efficiency not only aligns with clinical goals aimed at enhancing patient outcomes but also facilitates the expansion of testing capacities across hospitals, reference laboratories, and point-of-care facilities. Consequently, this trend is significantly contributing to the ongoing growth of the market in both emerging and established healthcare networks.

Restraints in the Global Multiplex Testing Reagents Market

The high costs associated with multiplex testing reagents stem from intricate manufacturing procedures and rigorous quality assurance measures necessary for consistent and dependable results. Healthcare providers in resource-limited environments often encounter budget restrictions that hinder investment in these specialized products. As a result, many institutions might delay the adoption of multiplex testing or opt for more affordable single-plex alternatives, which can inhibit market growth. This sensitivity to pricing affects the widespread integration of advanced multiplex technologies in various diagnostic fields and can influence the decisions related to long-term investment in innovative solutions.

Market Trends of the Global Multiplex Testing Reagents Market

The Global Multiplex Testing Reagents market is witnessing a significant trend towards automation integration, with laboratories increasingly adopting advanced robotic liquid-handling platforms. These high-capacity systems optimize multiplex reagent workflows by minimizing repetitive tasks, enhancing process uniformity, and reducing setup durations, thereby allowing skilled personnel to focus on more analytical duties. Furthermore, the incorporation of sophisticated scheduling software facilitates seamless synchronization of reagent loading with instrument operations, ensuring continuous functionality while maintaining high quality. This shift towards automation not only amplifies sample throughput, facilitating expansive clinical research and expedited diagnostic outcomes, but also diminishes error rates, reinforcing trust in multi-analyte testing across diverse regulatory landscapes.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porter's Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitutes
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Multiplex Testing Reagents Market Size by Reagent Type & CAGR (2026-2033)

  • Market Overview
  • Antibodies
  • Antigens
  • Nucleic Acid Probes
  • Enzymes
  • Detection Reagents
  • Others

Global Multiplex Testing Reagents Market Size by Testing Technology & CAGR (2026-2033)

  • Market Overview
  • Multiplex PCR
  • Multiplex Immunoassays
  • Microarray
  • Mass Spectrometry
  • Others

Global Multiplex Testing Reagents Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Infectious Disease Testing
  • Cancer Diagnostics
  • Genetic Testing
  • Food Safety Testing
  • Environmental Testing
  • Others

Global Multiplex Testing Reagents Market Size by End-Use Industry & CAGR (2026-2033)

  • Market Overview
  • Clinical Diagnostics
  • Pharmaceuticals & Biotechnology
  • Food & Beverage
  • Environmental Testing
  • Research & Academia
  • Others

Global Multiplex Testing Reagents Market Size & CAGR (2026-2033)

  • North America (Reagent Type, Testing Technology, Application, End-Use Industry)
    • US
    • Canada
  • Europe (Reagent Type, Testing Technology, Application, End-Use Industry)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Reagent Type, Testing Technology, Application, End-Use Industry)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Reagent Type, Testing Technology, Application, End-Use Industry)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Reagent Type, Testing Technology, Application, End-Use Industry)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Luminex
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Seegene
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Techne
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abcam
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DiaSorin
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molecular Devices
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenMark Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quanterix
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tecan
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations